N/A N=146 Randomized Supportive Care

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

Congestive Heart Failure · Sleep Apnea Syndromes

Bottom Line

View on ClinicalTrials.gov: NCT02312765 ↗

Enrolled (actual)

146

Serious AEs

23.3%

Results posted

Aug 2020

Primary outcome: Primary: Number of Participants Adhering to Positive Airway Pressure (PAP) — 5; 3 Participants — p=0.72

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: AirCare App (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Pennsylvania
Primary completion: Jun 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Adhering to Positive Airway Pressure (PAP)	5; 3	0.72

Summary

Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.

Eligibility Criteria

Inclusion Criteria

Congestive heart failure and sleep apnea

Exclusion Criteria

Cognitive impairment

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02312765). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.